Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-039590
Filing Date
2017-06-15
Accepted
2017-06-15 16:41:36
Documents
1
Period of Report
2017-06-13

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4256
  Complete submission text file 0001104659-17-039590.txt   5548
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2300 CORPORATE BOULEVARD N.W. SUITE 123 BOCA RATON FL 33431
Business Address
Hudson Frederick M. (Reporting) CIK: 0001438462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 17913924